Correlation Between Avient Corp and CERo Therapeutics
Can any of the company-specific risk be diversified away by investing in both Avient Corp and CERo Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avient Corp and CERo Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avient Corp and CERo Therapeutics Holdings, you can compare the effects of market volatilities on Avient Corp and CERo Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avient Corp with a short position of CERo Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avient Corp and CERo Therapeutics.
Diversification Opportunities for Avient Corp and CERo Therapeutics
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Avient and CERo is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Avient Corp and CERo Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CERo Therapeutics and Avient Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avient Corp are associated (or correlated) with CERo Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CERo Therapeutics has no effect on the direction of Avient Corp i.e., Avient Corp and CERo Therapeutics go up and down completely randomly.
Pair Corralation between Avient Corp and CERo Therapeutics
Given the investment horizon of 90 days Avient Corp is expected to under-perform the CERo Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Avient Corp is 15.53 times less risky than CERo Therapeutics. The stock trades about -0.69 of its potential returns per unit of risk. The CERo Therapeutics Holdings is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 1.98 in CERo Therapeutics Holdings on September 26, 2024 and sell it today you would lose (1.19) from holding CERo Therapeutics Holdings or give up 60.1% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Avient Corp vs. CERo Therapeutics Holdings
Performance |
Timeline |
Avient Corp |
CERo Therapeutics |
Avient Corp and CERo Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Avient Corp and CERo Therapeutics
The main advantage of trading using opposite Avient Corp and CERo Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avient Corp position performs unexpectedly, CERo Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CERo Therapeutics will offset losses from the drop in CERo Therapeutics' long position.The idea behind Avient Corp and CERo Therapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.CERo Therapeutics vs. Eupraxia Pharmaceuticals Common | CERo Therapeutics vs. Opus Genetics, | CERo Therapeutics vs. Telix Pharmaceuticals Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |